Differential interactions of estrogens and antiestrogens at the 17β-hydroxyl or counterpart hydroxyl with histidine 524 of the human estrogen receptor α

Biochemistry

Volumn 41, Issue 25, 2002, Pages 7979-7988

  Aliau, Sigrid ^a   Mattras, Hélène ^a   Richard, Eric ^a   Bonnafous, Jean Claude ^a   Borgna, Jean Louis ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING AFFINITY;

HORMONES; MUTAGENESIS;

BIOCHEMISTRY;

ANTIESTROGEN; ESTRADIOL; ESTROGEN RECEPTOR; HISTIDINE; HYDROXYL GROUP; RALOXIFENE;

ARTICLE; CRYSTAL STRUCTURE; DNA BINDING; LIGAND BINDING; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR BINDING; TRANSCRIPTION REGULATION;

ALANINE; AMINO ACID SUBSTITUTION; ANIMALS; BINDING SITES; COS CELLS; DIETHYL PYROCARBONATE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; HISTIDINE; HUMANS; HYDROXYL RADICAL; LIGANDS; RALOXIFENE; RECEPTORS, ESTROGEN; TAMOXIFEN;

EID: 0037172781     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0121914     Document Type: Article

References (36)

1. Estrogen receptor null mice: What we learned and where will they lead us?
2. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
3. The nuclear receptor superfamily: The second decade
4. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β
5. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene
6. Human œstrogen receptor cDNA: Sequence, expression and homology to v-erb-A
7. Sequence and expression of human estrogen receptor complementary DNA
8. ERβ: Identification and characterization of a novel human estrogen receptor
9. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
10. Ligand-protein interactions in nuclear receptors of hormones
11. Molecular basis of agonism and antagonism in the œstrogen receptor
12. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains
13. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
14. Overexpression, purification and crystal structure of native ERα LBD
15. Structure of the ligand-binding domain of œstrogen receptor beta in the presence of partial agonist and a full antagonist
16. Structural insights into the mode of action of a pure antiestrogen
17. A canonical structure for the ligand-binding domain of nuclear receptors
18. Identification of amino acids in the hormone binding domain of the human estrogen receptor important for estrogen binding
19. Different residues of the human estrogen receptor are involved in the recognition of structurally diverse estrogens and antiestrogens
20. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonte
21. Differential interactions of estrogens and antiestrogens at the 17β-hydroxy or counterpart function with the estrogen receptor
22. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding
23. Determination of protein-ligand binding constants at equilibrium in biological samples
24. Relation between estrogen receptor inhibitory activity and binding to cytosol of rabbit and human uterus
25. Equilibrium hormone binding to human estrogen receptors in highly diluted cell extracts is noncooperative and has a Kd of approximately 10 pM
26. 3H]4-hydoxytamoxifen
27. Modification of histidyl residues in proteins by diethylpyrocarbonate
28. The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site
29. Cysteine 530 of the human estrogen receptor α is the main covalent attachment site of 11α-(aziridinylalkoxyphenyl)-estradiols
30. The sheep estrogen receptor: Cloning and regulation of expression in the hypothalamo-pituitary axis
31. Pyrazole ligands: Structure-affinity/activity relationships and estrogen receptor-α-selective agonists
32. Crystal structure of a mutant hERα ligand-binding domain reveals key structural features for the mechanism of partial agonism
33. Control of the estrogen-like actions of the tamoxifen-estrogen receptor complex by the surface amino acid at position 351
34. An antiestrogen-responsive estrogen receptor α mutant (D351Y) shows weak AF-2 activity in the presence of tamoxifen
35. A single amino acid mutation of Ala-773 in the mineralocorticoid receptor confers agonist properties to 11β-substituted spirolactones